FDA Drug Master Files

Overview

The FDA Drug Master Files resource is a public listing mAIntained by the U.S. Food and Drug Administration. A Drug Master File, or DMF, is a submission to the FDA that may be used to provIDE confidential detailed Information about facilities, processes, or articles used in the manufACTuring, processing, packAGIng, and storing of one or more human drugs. This page is not a Generative AI product; it is a regulatory reference Database that teams can consult when researching DMF status and related submission records.

What it does

The listing presents DMF records subMITted to the FDA and gives users a way to check whether a particular Drug Master File has been filed. It is intended as a public infORMation resource for regulatory affairs Professionals, manufacturers, and others who need to underStand the regulatory landscape around drug substances and related materials.

Key capabilities

• Public DMF listing: Browse a directory of Drug Master Files recorded by the FDA.
• Regulatory reference: Supports due diligence and submission planning by showing which DMFs exist.
• Confidentiality-aware design: The DMF mechanism allows manufacturers to submit proprietary information while permitting authorized references by APPlicants.
• Authoritative source: Information comes directly from the U.S. federal drug regulator rather than a third-party aggregator.

Who it is for

This resource is useful for regulatory affairs specialists, phArmaceutical manufacturers, suppliers of drug substances and excipients, consultants, and legal or compliance teams involved in FDA submissions. Researchers and students studying pharmaceutical regulation may also find the listing informative. It is less relevant to general AI tool users, since it does not generate content, automate creative work, or provide AI model services.

How to get started

1. Open the FDA Drug Master Files page on the FDA website.
2. Review the listing of DMFs and any accompanying explanatory material.
3. Use the DMF number or holder information to cross-reference internal regulatory records.
4. Confirm current requirements and procedures with official FDA guidance before relying on any record for a submission.

Pricing and access caveat

Access to the public listing is Generally free and requires no account, though availability and page details may change as the FDA updates its systems. The database is a reference tool only and does not constitute legal or regulatory advice. Because DMF-related information can be confidential, the public listing may not include every detail, and users should verify status directly with official FDA resources. VeRSIon, update cadence, and specific field coveRAGe may vary and should be checked at the time of use.